212 related articles for article (PubMed ID: 35261320)
1. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')
Spyres MB; Padilla GK; Gerkin RD; Hoyte CO; Wolk BJ; Ruha AM;
Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
[TBL] [Abstract][Full Text] [Related]
2. Early Experience with Crotalidae Immune F(ab')
Ruha AM; Padilla-Jones A; Canning J; Spyres MB; Curry SC
J Med Toxicol; 2022 Jan; 18(1):38-42. PubMed ID: 34665424
[TBL] [Abstract][Full Text] [Related]
3. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
[TBL] [Abstract][Full Text] [Related]
4. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019.
Wilson BZ; Bahadir A; Andrews M; Karpen J; Winkler G; Smelski G; Dudley S; Walter FG; Shirazi FM
Toxicon; 2022 Apr; 209():10-17. PubMed ID: 35085602
[TBL] [Abstract][Full Text] [Related]
5. Use of both Fab and F(ab')
Martin AM; Wang GS; Poel K
Am J Emerg Med; 2021 Jul; 45():677.e1-677.e3. PubMed ID: 33293188
[TBL] [Abstract][Full Text] [Related]
6. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).
Bush SP; Green SM; Moynihan JA; Hayes WK; Cardwell MD
Ann Emerg Med; 2002 Dec; 40(6):619-24. PubMed ID: 12447339
[TBL] [Abstract][Full Text] [Related]
7. Comparison of F(ab')
Mascarenas DN; Fullerton L; Smolinske SC; Warrick BJ; Seifert SA
Toxicon; 2020 Oct; 186():42-45. PubMed ID: 32763251
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
Gerardo CJ; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Ryan S; Gasior M; Anderson VE; Lavonas EJ
Ann Emerg Med; 2017 Aug; 70(2):233-244.e3. PubMed ID: 28601268
[TBL] [Abstract][Full Text] [Related]
9. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
Seifert SA; Mascarenas DN; Fullerton L; Warrick BJ; Smolinske SC
Toxicon; 2020 Sep; 184():55-56. PubMed ID: 32505639
[TBL] [Abstract][Full Text] [Related]
10. Failure of Crotalidae Immune F(ab')
Levine M; Spungen H; Pizon AF
Ann Emerg Med; 2022 Dec; 80(6):525-527. PubMed ID: 35953386
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom.
Bebarta V; Dart RC
J Toxicol Clin Toxicol; 2004; 42(3):321-4. PubMed ID: 15362603
[TBL] [Abstract][Full Text] [Related]
12. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
Fazelat J; Teperman SH; Touger M
Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
[TBL] [Abstract][Full Text] [Related]
14. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
Keating GM
BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
[TBL] [Abstract][Full Text] [Related]
15. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
[TBL] [Abstract][Full Text] [Related]
16. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms.
Dudley S; Smelski G; Massey DJ; Maciulewicz T; Cardwell MD; Shirazi FM
Toxicon; 2022 Jun; 212():49-54. PubMed ID: 35413335
[TBL] [Abstract][Full Text] [Related]
17. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.
Kleinschmidt K; Ruha AM; Campleman S; Brent J; Wax P;
Clin Toxicol (Phila); 2018 Nov; 56(11):1115-1120. PubMed ID: 29688079
[No Abstract] [Full Text] [Related]
18. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.
Lavonas EJ; Schaeffer TH; Kokko J; Mlynarchek SL; Bogdan GM
BMC Emerg Med; 2009 Jun; 9():13. PubMed ID: 19545426
[TBL] [Abstract][Full Text] [Related]
19. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
[TBL] [Abstract][Full Text] [Related]
20. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.
Ruha AM; Curry SC; Beuhler M; Katz K; Brooks DE; Graeme KA; Wallace K; Gerkin R; Lovecchio F; Wax P; Selden B
Ann Emerg Med; 2002 Jun; 39(6):609-15. PubMed ID: 12023703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
